David M. Reboussin, PhD

Research Interests

Research

Joint modeling of systolic blood pressure and the primary outcome in Systolic Blood Pressure Intervention Trial. Reboussin DM, Whelton PK. J. Hypertens. 2019 08; 37(8):1729.
Who Is Exposed to E-Cigarette Advertising and Where? Differences between Adolescents, Young Adults and Older Adults. Wagoner KG, Reboussin DM, King JL, Orlan E, Cornacchione Ross J, Sutfin EL. Int J Environ Res Public Health. 2019 07; 16(14)
Analysis of Long-term Benefits of Intensive Blood Pressure Control-Reply. Reboussin DM, Pajewski NM, Williamson JD. JAMA. 2019 07; 322(2):170.
Evidence Supporting the Blood Pressure Treatment Goal of Less Than 130/80 mm?Hg. Reboussin DM, Carey RM, Whelton PK. Hypertension. 2019 05; 73(5):972-974.
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. , Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Erus G, Fine LJ, Gaussoin SA, Harris D, Hsieh MK, Johnson KC, Kimmel PL, Tamura MK, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nasrallah IM, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT, Wright CB. JAMA. 2019 02; 321(6):553-561.

View More Publications